Center for Professional Innovation & Education, Inc., Los Angeles, CA
Dec. 8 & 9, 2014
The FDA and the FTC are carefully watching cosmetic products for non-substantiated misleading claims. If the claim is indeed misleading the consumer and results in the purchase of a product that will not deliver its promised benefit, it becomes an immediate matter of concern to regulatory agencies. With the cosmetic industry striving to produce safer products, scientific resources should be focused on better testing products for their activity on the skin while meeting all product claims. Common criteria for justification of claims are a challenging aspect in product development since it needs to be customized for the purpose of use and nature of the product developed. This course is tailored to provide key aspects in the establishment of best practices to be applied in experimental design. Additionally, the program will cover methods for implementing a sound regulatory framework which will meet all government/agency requirements.
|
|
Invited Speakers:
|
|
Nava Dayan is a skin-care and health expert with nearly 25 years of industry experience. Her experience includes skin research and development systems in the personal care, cosmetics, pharmaceutical, medical-device and delivery-system industries. As an independent consultant, Dr. Dayan offers a wide range of services to those industries. Her expertise includes product innovation, skin biochemistry, the development of ingredients and formulations, delivery systems for both dermal and transdermal applications, prevention of adverse effects, safety assessment, claim substantiation via clinical study design, execution and data interpretation. Dr. Dayan teaches courses on Biomarkers in Skin Care, Claim Substantiation for Topical Products, Pathways to Skin Penetration, Safety Assessment of Cosmetic Ingredients and Formulations, Skin Inflammation and Dermal Product Development. Dr. Dayan received her Ph.D. in Pharmaceutics specializing in skin delivery from the Hebrew University in Jerusalem.
|
|